FXR-FGF19 signaling in the gut–liver axis is dysregulated in patients with cirrhosis and correlates with impaired intestinal defenceBenedikt Simbrunner, Thomas Reiberger, Benedikt Hofer et al.|Hepatology International|2024Cited by 19
Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver DiseaseBenedikt Simbrunner, Diana Julie Leeming, Ida Falk Villesen et al.|Alimentary Pharmacology & Therapeutics|2025Cited by 9
Inflammation remains a dynamic component of portal hypertension in regressive alcohol‐related cirrhosisBenedikt Hofer, Thomas Reiberger, Benedikt Simbrunner et al.|United European Gastroenterology Journal|2024Cited by 8
Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosisBenedikt Hofer, Thomas Reiberger, Ksenia Brusilovskaya et al.|Digestive and Liver Disease|2024Cited by 5
Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis modelsThomas Sorz, Thomas Reiberger, Ksenia Brusilovskaya et al.|Scientific Reports|2025Cited by 4